Prevalence and Risk Factors of GERD among Stable COPD Patients
Downloads
Introduction: Gastroesophageal reflux disease (GERD) is one of the most common causes of a chronic cough and is a potential risk factor for chronic obstructive pulmonary disease (COPD) exacerbation. This study aimed to determine the prevalence of GERD in COPD patients.
Methods: This was a cross-sectional study involving 40 stable COPD patients recruited from outpatient asthma and COPD clinics at Persahabatan National Respiratory Referral Hospital, Jakarta, from May to November 2018. COPD was defined as having a ratio of post-bronchodilator FEV1/FVC < 0.7 and no abnormality on a chest X-ray except emphysematous. Diagnosis of GERD was based on oesophageal mucosal lining break surrounding the distal esophageal sphincter through esophagogastroduodenoscopy (EGD). Asthma patients with known esophageal diseases such as cancer, achalasia, and active peptic ulcer and patients who had used proton pump inhibitors in the last 15 days were excluded.
Results: Patients were divided into GERD (+) (16/40, 40%) and GERD (-) (24/40, 60%). Subjects were predominantly elderly (25/40, 62.5%) and had a smoking history (36/40, 90%). Exacerbation and COPD assessment test (CAT) score was significantly associated with GERD (p < 0.05). No significant difference regarding age, sex, Brinkman Index, lung function, and body mass index (BMI) was found between groups. However, the GERD (+) group showed a slightly higher BMI and more severe airflow obstruction.
Conclusion: The prevalence of GERD in COPD patients found in this study was as high as 40%. A cohort study and preventive strategy of GERD in COPD should be studied further.
(GOLD) GI for COLD. GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of COPD. Illinois, https://goldcopd.org/gold-2017-global-strategy-diagnosis-management- prevention-copd/ (2017).
Sanchez J, Schumann DM, Karakioulaki M, et al. Laryngopharyngeal Reflux in Chronic Obstructive Pulmonary Disease - A Multi-Centre Study. Respir Res 2020; 21: 220. [Journal]
Sweet MP, Patti MG, Hoopes C, et al. Gastro-Oesophageal Reflux and Aspiration in Patients with Advanced Lung Disease. Thorax 2009; 64: 167–173. [PubMed]
Fujiwara Y, Arakawa T. Epidemiology and Clinical Characteristics of GERD in the Japanese Population. J Gastroenterol 2009; 44: 518–534. [PubMed]
El-Serag HB, Sweet S, Winchester CC, et al. Update on the Epidemiology of Gastro-Oesophageal Reflux Disease: A Systematic Review. Gut 2014; 63: 871–880. [PubMed]
Lee AL, Goldstein RS. Gastroesophageal Reflux Disease in COPD: Links and Risks. Int J Chron Obstruct Pulmon Dis 2015; 10: 1935–1949. [PubMed]
Lelosutan SAR, Manan C, Nur BM. The Role of Gastric Acidity and Lower Esophageal Sphincter Tone on Esophagitis in Patients with Dyspepsia. Indones J Gastroenterol Hepatol Dig Endosc 2001; 2: 6–11. [Journal]
Syam AF, Miftahussurur M, Makmun D, et al. Risk Factors and Prevalence of Helicobacter pylori in Five Largest Islands of Indonesia: A Preliminary Study. PLoS One 2015; 10: e0140186. [PubMed]
Susanto AD, Lelosutan SAR, Sawitri N, et al. Gambaran Klinis dan Endoskopi Penyakit Refluks Gastroesofagus (PRGE) pada Pasien Asma Persisten Sedang di RS Persahabatan, Jakarta. J Respirologi Indones 2009; 29: 31–38. [Journal]
Lee AL, Button BM, Denehy L, et al. Proximal and Distal Gastro-Oesophageal Reflux in Chronic Obstructive Pulmonary Disease and Bronchiectasis. Respirology 2014; 19: 211–217. [PubMed]
Iliaz S, Iliaz R, Onur ST, et al. Does Gastroesophageal Reflux Increase Chronic Obstructive Pulmonary Disease Exacerbations? Respir Med 2016; 115: 20–25. [PubMed]
Baumeler L, Papakonstantinou E, Milenkovic B, et al. Therapy with Proton-Pump Inhibitors for Gastroesophageal Reflux Disease Does Not Reduce the Risk for Severe Exacerbations in COPD. Respirology 2016; 21: 883–890. [PubMed]
Lin YH, Tsai CL, Chien LN, et al. Newly Diagnosed Gastroesophageal Reflux Disease Increased the Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease during the First Year Following Diagnosis--A Nationwide Population-Based Cohort Study. Int J Clin Pract 2015; 69: 350–357. [PubMed]
Khamitov R, Zinnatullina A. Study of Gastroesophageal Reflux Disease in Frequent Exacerbations of Chronic Obstructive Pulmonary Disease. Eur Respir J 2021; 58: PA2225. [Journal]
Bigatao AM, Herbella FAM, Del Grande LM, et al. Chronic Obstructive Pulmonary Disease Exacerbations are Influenced by Gastroesophageal Reflux Disease. Am Surg 2018; 84: 51–55. [PubMed]
Broers C, Tack J, Pauwels A. Review Article: Gastro-Oesophageal Reflux Disease in Asthma and Chronic Obstructive Pulmonary Disease. Aliment Pharmacol Ther 2018; 47: 176–191. [PubMed]
Su VY-F, Liao H-F, Perng D-W, et al. Proton Pump Inhibitors Use is associated with a Lower Risk of Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD. Int J Chron Obstruct Pulmon Dis 2018; 13: 2907–2915. [PubMed]
Ingebrigtsen TS, Marott JL, Vestbo J, et al. Gastro-Esophageal Reflux Disease and Exacerbations in Chronic Obstructive Pulmonary Disease. Respirology 2015; 20: 101–107. [PubMed]
Kang HH, Seo M, Lee J, et al. Reflux Esophagitis in Patients with Chronic Obstructive Pulmonary Disease. Medicine (Baltimore) 2021; 100: e27091.[PubMed]
Özdemir P, Erdinç M, Vardar R, et al. The Role of Microaspiration in the Pathogenesis of Gastroesophageal Reflux-related Chronic Cough. J Neurogastroenterol Motil 2017; 23: 41–48. [PubMed]
Copyright (c) 2023 Muhammad Hafiz, Faisal Yunus, Maulana Suryamin2,3, Mohammad Fahmi Alatas, Adityo Wibowo
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.